Shares of Unitree, one of China’s foremost manufacturers of humanoid robots, surged by as much as 629% during its initial public trading debut in Shanghai on Wednesday, underscoring the latest wave of investor enthusiasm surrounding China’s technological progress.

Established in 2016 by entrepreneur Wang Xingxing in Hangzhou, the eastern Chinese technology hub, the company secured approximately 6.1 billion yuan ($904 million) through its debut on the Shanghai Stock Exchange’s Nasdaq-style STAR market.

Priced at 150.80 yuan ($22.36) per share, its stock concluded the trading session with a staggering 460% surge, closing at 845 yuan ($125.31).

Advanced robotics, often described as "embodied" artificial intelligence, is a key sector in the intense technological competition between China and the U.S.

China leads the U.S. in humanoid robot production capacity and in its ability to scale up manufacturing.

Last year, of the roughly 15,000 humanoid robots shipped globally, Unitree and AGIBOT, another major Chinese humanoid robot maker, each shipped more than 5,000, according to technology research and advisory group Omdia, way ahead of their U.S. counterparts.

For the first half of 2026, Omdia’s estimates put Chinese humanoid robot makers’ total global shipments at around 18,500 units.

Analysts contend, however, that for the time being, many of these humanoid robots remain largely confined to demonstrations, performances, and research endeavors rather than practical, real-world deployment.

Unitree’s humanoid robots, for instance, captivated audiences at China’s annual Spring Festival gala with acrobatic backflips and martial-arts routines.

"The real competitive test will be whether companies – Chinese or American – can achieve reliable performance and attractive returns on investment in large-scale industrial and commercial deployments," analyst Kangyuxiao Li at investment research firm Morningstar said in a commentary.

Unitree stated that the proceeds from the IPO will be allocated to advanced robotics research and development, as well as the expansion of its robot manufacturing facility.

The company stands as the first publicly traded manufacturer of humanoid robotics in mainland China.

Analysts contend that the initial public offering could establish a benchmark for the valuation of subsequent robotics firms' stock offerings.

According to Li at Morningstar, this affords mainland investors direct access to one of the sector's foremost companies.

Unitree’s debut coincided with the World Robot Conference in Beijing, which attracted more than 300 exhibitors.

Chinese leaders have prioritized robotics as a key area of national development.

UBTech, another prominent Chinese manufacturer of humanoid robots, is listed on the Hong Kong stock exchange, where its shares experienced a decline of more than 10% on Wednesday.

Unitree reported approximately 1.7 billion yuan (about $250 million) in revenue for 2025, derived primarily from sales of its humanoid robots and quadruped robots, commonly referred to as four-legged robot dogs.

Over 40% of that revenue originated from overseas markets.

Last year, the U.S. accounted for roughly 13% of Unitree’s revenue, the company said.

However, that was prior to the U.S. Federal Communications Commission’s July ban on imports of new foreign-made humanoid and quadruped robots, imposed on national security grounds.

Unitree cautioned that the U.S. ban, which it said applies to its new models, could affect its future sales in the U.S. market.

Existing models of its advanced robots can still be sold, but Unitree faces the risk that the U.S. could further expand its restrictions.

Lian Jye Su of Omdia observed that Chinese robot manufacturers are likely to seek expansion into key markets outside the United States, such as Europe.